Posted in | News | Uranium

Paladin Energy Mulls NGM Resources Takeover

Paladin Energy Ltd (ASX:PDN) is in talks to take over NGM Resources Ltd (ASX: NGM). NGM is a diversified mineral exploration company with a focus on uranium and base metals.

It is based in Perth and has agreements for uranium exploration projects in Niger, West Africa and some metal exploration projects in Madagascar in Southern Africa.

Given Paladin Energy's focus in Africa and strategy to become a major uranium mining house NGM seems a logical acquisition. While the company is yet to make a decision on the takeover, Paladin is undertaking due diligence on NGM and is negotiating with the Board of NGM in terms of a potential takeover bid.

The market capitalisation of NGM is $16.78 million, while Paladin's market capitalisation is $2.59 billion. Niger is the world's fourth largest uranium producer and last week NGM announced success at its drilling program in Niger's Tim Mersoi basin. Promising iron ore and mineral sand concessions have been identified by NGM in Madagascar as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Paladin Energy Ltd. (2019, March 19). Paladin Energy Mulls NGM Resources Takeover. AZoMining. Retrieved on April 23, 2024 from https://www.azomining.com/News.aspx?newsID=148.

  • MLA

    Paladin Energy Ltd. "Paladin Energy Mulls NGM Resources Takeover". AZoMining. 23 April 2024. <https://www.azomining.com/News.aspx?newsID=148>.

  • Chicago

    Paladin Energy Ltd. "Paladin Energy Mulls NGM Resources Takeover". AZoMining. https://www.azomining.com/News.aspx?newsID=148. (accessed April 23, 2024).

  • Harvard

    Paladin Energy Ltd. 2019. Paladin Energy Mulls NGM Resources Takeover. AZoMining, viewed 23 April 2024, https://www.azomining.com/News.aspx?newsID=148.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.